Association of preconception paternal health and adverse maternal outcomes among healthy mothers
Maternal morbidity continues to be an issue of national and global concern. Paternal preconception health may play a significant role in pregnancy outcomes and has received less attention than maternal health. This study aimed to examine the association between preconception paternal health and the...
Gespeichert in:
Veröffentlicht in: | American journal of obstetrics & gynecology MFM 2021-09, Vol.3 (5), p.100384-100384, Article 100384 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 100384 |
---|---|
container_issue | 5 |
container_start_page | 100384 |
container_title | American journal of obstetrics & gynecology MFM |
container_volume | 3 |
creator | Murugappan, Gayathree Li, Shufeng Leonard, Stephanie A. Winn, Virginia D. Druzin, Maurice L. Eisenberg, Michael L. |
description | Maternal morbidity continues to be an issue of national and global concern. Paternal preconception health may play a significant role in pregnancy outcomes and has received less attention than maternal health.
This study aimed to examine the association between preconception paternal health and the risk for adverse maternal outcomes among healthy mothers.
This was a retrospective analysis of live births from 2009 through 2016 to healthy women aged 20 to 45 years recorded in the IBM Marketscan research database. Infants were linked to paired mothers and fathers using family ID. Preconception paternal health was assessed using the number of metabolic syndrome component diagnoses and the most common individual chronic disease diagnoses (hypertension, diabetes mellitus, obesity, hyperlipidemia, chronic obstructive pulmonary disease, cancer, and depression). Women with metabolic syndrome components were excluded to avoid potential confounding of maternal and paternal factors. Adverse maternal outcomes that were assessed included (1) abnormal placentation including placenta accreta spectrum, placenta previa, and placental abruption; (2) preeclampsia with and without severe features including eclampsia; and (3) severe maternal morbidity, identified as any indicator from the Centers for Disease Control and Prevention Index of life-threatening complications at the time of delivery to 6 weeks postpartum. The trend between preconception paternal health and each maternal outcome was determined using the Cochran-Armitage Trend test. The independent association of paternal health with maternal outcomes was also determined using generalized estimating equations models, accounting for some mothers who contributed multiple births during the study period, and by adjusting for maternal age, paternal age, region of birth, year of birth, maternal smoking, and average number of outpatient visits per year.
Among 669,256 births to healthy mothers, there was a significant trend between all adverse maternal outcomes and worsening preconception paternal health defined either as the number of metabolic syndrome diagnoses or number of chronic disease diagnoses (P |
doi_str_mv | 10.1016/j.ajogmf.2021.100384 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2518738099</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2589933321000793</els_id><sourcerecordid>2518738099</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-ed6fc26ea1fea6b80c5801e3da57806fec4efb26e4a2f2be19399d7aa4c0aa3c3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0Eoqj0DxDKkk2KH0mabJCqipdUiQ2szcQZt4mSONhJpf49LmkRK1a2Zs74jg8hN4zOGWXJfTWHymwaPeeUM1-iIo3OyBWP0yzMhBDnf-4TMnOuotSTURTz5JJMhEizWGTZFflcOmdUCX1p2sDooLOoTKuw-yl00KNtoQ62CHW_DaAtAih2aB0Gzalnhl6ZBl0AjWk3R3QfNKbfevCaXGioHc6O55R8PD2-r17C9dvz62q5DpVIeB9ikWjFEwSmEZI8pSpOKUNRQLxIaaJRRahzD0TANc-RZX79YgEQKQoglJiSu_HdzpqvAV0vm9IprGto0QxO8pilC5HSLPNoNKLKGucsatnZsgG7l4zKg15ZyVGvPOiVo14_dntMGPIGi9-hk0wPPIwA-n_uSrTSqRK9zKL0VntZmPL_hG8iuo_y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2518738099</pqid></control><display><type>article</type><title>Association of preconception paternal health and adverse maternal outcomes among healthy mothers</title><source>Alma/SFX Local Collection</source><creator>Murugappan, Gayathree ; Li, Shufeng ; Leonard, Stephanie A. ; Winn, Virginia D. ; Druzin, Maurice L. ; Eisenberg, Michael L.</creator><creatorcontrib>Murugappan, Gayathree ; Li, Shufeng ; Leonard, Stephanie A. ; Winn, Virginia D. ; Druzin, Maurice L. ; Eisenberg, Michael L.</creatorcontrib><description>Maternal morbidity continues to be an issue of national and global concern. Paternal preconception health may play a significant role in pregnancy outcomes and has received less attention than maternal health.
This study aimed to examine the association between preconception paternal health and the risk for adverse maternal outcomes among healthy mothers.
This was a retrospective analysis of live births from 2009 through 2016 to healthy women aged 20 to 45 years recorded in the IBM Marketscan research database. Infants were linked to paired mothers and fathers using family ID. Preconception paternal health was assessed using the number of metabolic syndrome component diagnoses and the most common individual chronic disease diagnoses (hypertension, diabetes mellitus, obesity, hyperlipidemia, chronic obstructive pulmonary disease, cancer, and depression). Women with metabolic syndrome components were excluded to avoid potential confounding of maternal and paternal factors. Adverse maternal outcomes that were assessed included (1) abnormal placentation including placenta accreta spectrum, placenta previa, and placental abruption; (2) preeclampsia with and without severe features including eclampsia; and (3) severe maternal morbidity, identified as any indicator from the Centers for Disease Control and Prevention Index of life-threatening complications at the time of delivery to 6 weeks postpartum. The trend between preconception paternal health and each maternal outcome was determined using the Cochran-Armitage Trend test. The independent association of paternal health with maternal outcomes was also determined using generalized estimating equations models, accounting for some mothers who contributed multiple births during the study period, and by adjusting for maternal age, paternal age, region of birth, year of birth, maternal smoking, and average number of outpatient visits per year.
Among 669,256 births to healthy mothers, there was a significant trend between all adverse maternal outcomes and worsening preconception paternal health defined either as the number of metabolic syndrome diagnoses or number of chronic disease diagnoses (P<.001; Cochran-Armitage Trend test). In the generalized estimating equations model, the odds for preeclampsia without severe features increased in a dose-dependent fashion and were 21% higher (95% confidence interval, 1.17–1.26) among women whose partners had ≥2 metabolic syndrome diagnoses than among women whose partners had no metabolic syndrome diagnosis. The odds for preeclampsia with severe features and eclampsia increased in a dose-dependent fashion and were 19% higher (95% confidence interval, 1.09–1.30) among women whose partners had ≥2 metabolic syndrome diagnoses than among women whose partners had no metabolic syndrome diagnosis. The odds for severe maternal morbidity were 9% higher (95% confidence interval, 1.002–1.19) among women whose partners had ≥2 metabolic syndrome diagnoses than among women whose partners had no metabolic syndrome diagnosis. The odds for abnormal placentation were similar between the groups (adjusted odds ratio, 0.96; 95% confidence interval, 0.89–1.03).
Among healthy mothers, we report that preconception paternal health is significantly associated with increased odds of preeclampsia with and without severe features and weakly associated with increased odds of severe maternal morbidity. These findings suggest that paternally derived factors may play significant roles in the development of adverse maternal outcomes in healthy women with a low a priori risk of obstetrical complications.</description><identifier>ISSN: 2589-9333</identifier><identifier>EISSN: 2589-9333</identifier><identifier>DOI: 10.1016/j.ajogmf.2021.100384</identifier><identifier>PMID: 33895399</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>adverse pregnancy outcomes ; maternal health ; maternal morbidity ; paternal health ; preconception paternal health</subject><ispartof>American journal of obstetrics & gynecology MFM, 2021-09, Vol.3 (5), p.100384-100384, Article 100384</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright © 2021. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-ed6fc26ea1fea6b80c5801e3da57806fec4efb26e4a2f2be19399d7aa4c0aa3c3</citedby><cites>FETCH-LOGICAL-c362t-ed6fc26ea1fea6b80c5801e3da57806fec4efb26e4a2f2be19399d7aa4c0aa3c3</cites><orcidid>0000-0003-4084-0365</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33895399$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murugappan, Gayathree</creatorcontrib><creatorcontrib>Li, Shufeng</creatorcontrib><creatorcontrib>Leonard, Stephanie A.</creatorcontrib><creatorcontrib>Winn, Virginia D.</creatorcontrib><creatorcontrib>Druzin, Maurice L.</creatorcontrib><creatorcontrib>Eisenberg, Michael L.</creatorcontrib><title>Association of preconception paternal health and adverse maternal outcomes among healthy mothers</title><title>American journal of obstetrics & gynecology MFM</title><addtitle>Am J Obstet Gynecol MFM</addtitle><description>Maternal morbidity continues to be an issue of national and global concern. Paternal preconception health may play a significant role in pregnancy outcomes and has received less attention than maternal health.
This study aimed to examine the association between preconception paternal health and the risk for adverse maternal outcomes among healthy mothers.
This was a retrospective analysis of live births from 2009 through 2016 to healthy women aged 20 to 45 years recorded in the IBM Marketscan research database. Infants were linked to paired mothers and fathers using family ID. Preconception paternal health was assessed using the number of metabolic syndrome component diagnoses and the most common individual chronic disease diagnoses (hypertension, diabetes mellitus, obesity, hyperlipidemia, chronic obstructive pulmonary disease, cancer, and depression). Women with metabolic syndrome components were excluded to avoid potential confounding of maternal and paternal factors. Adverse maternal outcomes that were assessed included (1) abnormal placentation including placenta accreta spectrum, placenta previa, and placental abruption; (2) preeclampsia with and without severe features including eclampsia; and (3) severe maternal morbidity, identified as any indicator from the Centers for Disease Control and Prevention Index of life-threatening complications at the time of delivery to 6 weeks postpartum. The trend between preconception paternal health and each maternal outcome was determined using the Cochran-Armitage Trend test. The independent association of paternal health with maternal outcomes was also determined using generalized estimating equations models, accounting for some mothers who contributed multiple births during the study period, and by adjusting for maternal age, paternal age, region of birth, year of birth, maternal smoking, and average number of outpatient visits per year.
Among 669,256 births to healthy mothers, there was a significant trend between all adverse maternal outcomes and worsening preconception paternal health defined either as the number of metabolic syndrome diagnoses or number of chronic disease diagnoses (P<.001; Cochran-Armitage Trend test). In the generalized estimating equations model, the odds for preeclampsia without severe features increased in a dose-dependent fashion and were 21% higher (95% confidence interval, 1.17–1.26) among women whose partners had ≥2 metabolic syndrome diagnoses than among women whose partners had no metabolic syndrome diagnosis. The odds for preeclampsia with severe features and eclampsia increased in a dose-dependent fashion and were 19% higher (95% confidence interval, 1.09–1.30) among women whose partners had ≥2 metabolic syndrome diagnoses than among women whose partners had no metabolic syndrome diagnosis. The odds for severe maternal morbidity were 9% higher (95% confidence interval, 1.002–1.19) among women whose partners had ≥2 metabolic syndrome diagnoses than among women whose partners had no metabolic syndrome diagnosis. The odds for abnormal placentation were similar between the groups (adjusted odds ratio, 0.96; 95% confidence interval, 0.89–1.03).
Among healthy mothers, we report that preconception paternal health is significantly associated with increased odds of preeclampsia with and without severe features and weakly associated with increased odds of severe maternal morbidity. These findings suggest that paternally derived factors may play significant roles in the development of adverse maternal outcomes in healthy women with a low a priori risk of obstetrical complications.</description><subject>adverse pregnancy outcomes</subject><subject>maternal health</subject><subject>maternal morbidity</subject><subject>paternal health</subject><subject>preconception paternal health</subject><issn>2589-9333</issn><issn>2589-9333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0Eoqj0DxDKkk2KH0mabJCqipdUiQ2szcQZt4mSONhJpf49LmkRK1a2Zs74jg8hN4zOGWXJfTWHymwaPeeUM1-iIo3OyBWP0yzMhBDnf-4TMnOuotSTURTz5JJMhEizWGTZFflcOmdUCX1p2sDooLOoTKuw-yl00KNtoQ62CHW_DaAtAih2aB0Gzalnhl6ZBl0AjWk3R3QfNKbfevCaXGioHc6O55R8PD2-r17C9dvz62q5DpVIeB9ikWjFEwSmEZI8pSpOKUNRQLxIaaJRRahzD0TANc-RZX79YgEQKQoglJiSu_HdzpqvAV0vm9IprGto0QxO8pilC5HSLPNoNKLKGucsatnZsgG7l4zKg15ZyVGvPOiVo14_dntMGPIGi9-hk0wPPIwA-n_uSrTSqRK9zKL0VntZmPL_hG8iuo_y</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Murugappan, Gayathree</creator><creator>Li, Shufeng</creator><creator>Leonard, Stephanie A.</creator><creator>Winn, Virginia D.</creator><creator>Druzin, Maurice L.</creator><creator>Eisenberg, Michael L.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4084-0365</orcidid></search><sort><creationdate>20210901</creationdate><title>Association of preconception paternal health and adverse maternal outcomes among healthy mothers</title><author>Murugappan, Gayathree ; Li, Shufeng ; Leonard, Stephanie A. ; Winn, Virginia D. ; Druzin, Maurice L. ; Eisenberg, Michael L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-ed6fc26ea1fea6b80c5801e3da57806fec4efb26e4a2f2be19399d7aa4c0aa3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>adverse pregnancy outcomes</topic><topic>maternal health</topic><topic>maternal morbidity</topic><topic>paternal health</topic><topic>preconception paternal health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murugappan, Gayathree</creatorcontrib><creatorcontrib>Li, Shufeng</creatorcontrib><creatorcontrib>Leonard, Stephanie A.</creatorcontrib><creatorcontrib>Winn, Virginia D.</creatorcontrib><creatorcontrib>Druzin, Maurice L.</creatorcontrib><creatorcontrib>Eisenberg, Michael L.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics & gynecology MFM</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murugappan, Gayathree</au><au>Li, Shufeng</au><au>Leonard, Stephanie A.</au><au>Winn, Virginia D.</au><au>Druzin, Maurice L.</au><au>Eisenberg, Michael L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of preconception paternal health and adverse maternal outcomes among healthy mothers</atitle><jtitle>American journal of obstetrics & gynecology MFM</jtitle><addtitle>Am J Obstet Gynecol MFM</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>3</volume><issue>5</issue><spage>100384</spage><epage>100384</epage><pages>100384-100384</pages><artnum>100384</artnum><issn>2589-9333</issn><eissn>2589-9333</eissn><abstract>Maternal morbidity continues to be an issue of national and global concern. Paternal preconception health may play a significant role in pregnancy outcomes and has received less attention than maternal health.
This study aimed to examine the association between preconception paternal health and the risk for adverse maternal outcomes among healthy mothers.
This was a retrospective analysis of live births from 2009 through 2016 to healthy women aged 20 to 45 years recorded in the IBM Marketscan research database. Infants were linked to paired mothers and fathers using family ID. Preconception paternal health was assessed using the number of metabolic syndrome component diagnoses and the most common individual chronic disease diagnoses (hypertension, diabetes mellitus, obesity, hyperlipidemia, chronic obstructive pulmonary disease, cancer, and depression). Women with metabolic syndrome components were excluded to avoid potential confounding of maternal and paternal factors. Adverse maternal outcomes that were assessed included (1) abnormal placentation including placenta accreta spectrum, placenta previa, and placental abruption; (2) preeclampsia with and without severe features including eclampsia; and (3) severe maternal morbidity, identified as any indicator from the Centers for Disease Control and Prevention Index of life-threatening complications at the time of delivery to 6 weeks postpartum. The trend between preconception paternal health and each maternal outcome was determined using the Cochran-Armitage Trend test. The independent association of paternal health with maternal outcomes was also determined using generalized estimating equations models, accounting for some mothers who contributed multiple births during the study period, and by adjusting for maternal age, paternal age, region of birth, year of birth, maternal smoking, and average number of outpatient visits per year.
Among 669,256 births to healthy mothers, there was a significant trend between all adverse maternal outcomes and worsening preconception paternal health defined either as the number of metabolic syndrome diagnoses or number of chronic disease diagnoses (P<.001; Cochran-Armitage Trend test). In the generalized estimating equations model, the odds for preeclampsia without severe features increased in a dose-dependent fashion and were 21% higher (95% confidence interval, 1.17–1.26) among women whose partners had ≥2 metabolic syndrome diagnoses than among women whose partners had no metabolic syndrome diagnosis. The odds for preeclampsia with severe features and eclampsia increased in a dose-dependent fashion and were 19% higher (95% confidence interval, 1.09–1.30) among women whose partners had ≥2 metabolic syndrome diagnoses than among women whose partners had no metabolic syndrome diagnosis. The odds for severe maternal morbidity were 9% higher (95% confidence interval, 1.002–1.19) among women whose partners had ≥2 metabolic syndrome diagnoses than among women whose partners had no metabolic syndrome diagnosis. The odds for abnormal placentation were similar between the groups (adjusted odds ratio, 0.96; 95% confidence interval, 0.89–1.03).
Among healthy mothers, we report that preconception paternal health is significantly associated with increased odds of preeclampsia with and without severe features and weakly associated with increased odds of severe maternal morbidity. These findings suggest that paternally derived factors may play significant roles in the development of adverse maternal outcomes in healthy women with a low a priori risk of obstetrical complications.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33895399</pmid><doi>10.1016/j.ajogmf.2021.100384</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4084-0365</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2589-9333 |
ispartof | American journal of obstetrics & gynecology MFM, 2021-09, Vol.3 (5), p.100384-100384, Article 100384 |
issn | 2589-9333 2589-9333 |
language | eng |
recordid | cdi_proquest_miscellaneous_2518738099 |
source | Alma/SFX Local Collection |
subjects | adverse pregnancy outcomes maternal health maternal morbidity paternal health preconception paternal health |
title | Association of preconception paternal health and adverse maternal outcomes among healthy mothers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T15%3A03%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20preconception%20paternal%20health%20and%20adverse%20maternal%20outcomes%20among%20healthy%20mothers&rft.jtitle=American%20journal%20of%20obstetrics%20&%20gynecology%20MFM&rft.au=Murugappan,%20Gayathree&rft.date=2021-09-01&rft.volume=3&rft.issue=5&rft.spage=100384&rft.epage=100384&rft.pages=100384-100384&rft.artnum=100384&rft.issn=2589-9333&rft.eissn=2589-9333&rft_id=info:doi/10.1016/j.ajogmf.2021.100384&rft_dat=%3Cproquest_cross%3E2518738099%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2518738099&rft_id=info:pmid/33895399&rft_els_id=S2589933321000793&rfr_iscdi=true |